{"disease":{"id":"odi","name":"odi"},"drugs":{"marketed":[{"drug_id":"canakinumab","indication_name":"Cryopyrin associated periodic syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ilaris","generic_name":"CANAKINUMAB","company_name":"Novartis Pharms","drug_phase":"marketed","molecular_target":"Interleukin-1 beta","drug_class":"Non-Standardized Plant Allergenic Extract [EPC]","quality_score":59,"revenue":"1369","mechanism":""},{"drug_id":"canakinumab","indication_name":"TNF receptor-associated periodic fever syndrome (TRAPS)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ilaris","generic_name":"CANAKINUMAB","company_name":"Novartis Pharms","drug_phase":"marketed","molecular_target":"Interleukin-1 beta","drug_class":"Non-Standardized Plant Allergenic Extract [EPC]","quality_score":59,"revenue":"1369","mechanism":""},{"drug_id":"galcanezumab","indication_name":"Treatment of episodic cluster headache","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Emgality","generic_name":"GALCANEZUMAB","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Calcitonin gene-related peptide 1","drug_class":"","quality_score":60,"revenue":"500","mechanism":"Emgality works by binding to calcitonin gene-related peptide 1 (CGRP1), preventing it from triggering migraine attacks."},{"drug_id":"atogepant","indication_name":"Preventive treatment of episodic migraine in adults","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Qulipta","generic_name":"ATOGEPANT","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"Calcitonin gene-related peptide type 1 receptor","drug_class":"Calcitonin Gene-related Peptide Receptor Antagonist [EPC]","quality_score":66,"revenue":"201","mechanism":"Qulipta works by blocking the action of a natural chemical called calcitonin gene-related peptide type 1, which is involved in migraine pain."},{"drug_id":"fremanezumab-vfrm","indication_name":"Preventive treatment of episodic migraine in pediatric patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fremanezumab-Vfrm","company_name":"Manhattan Beach Orthodontics","drug_phase":"marketed","molecular_target":"calcitonin gene-related peptide (CGRP)","drug_class":"","quality_score":40,"revenue":null,"mechanism":"Fremanezumab-vfrm binds to CGRP and blocks its interaction with the receptor."},{"drug_id":"potassium-bicarbonate","indication_name":"Hypokalemic Familial Periodic Paralysis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"POTASSIUM BICARBONATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":14,"revenue":null,"mechanism":null},{"drug_id":"fusidic-acid","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ramycin","generic_name":"FUSIDIC ACID","company_name":"","drug_phase":"phase_3","molecular_target":"Bile salt export pump","drug_class":"fusidic acid","quality_score":47,"revenue":null,"mechanism":"Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins."},{"drug_id":"doxycyclin","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Doxycyclin","company_name":"Bulovka Hospital","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"hydroxychloroquine-pill","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"hydroxychloroquine-pill","company_name":"Sanofi","drug_phase":"discontinued","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":null,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and modulating the immune system to treat autoimmune diseases."},{"drug_id":"hydroxychloroquine-pill","indication_name":"Plasmodium Malariae Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"hydroxychloroquine-pill","company_name":"Sanofi","drug_phase":"discontinued","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":null,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and modulating the immune system to treat autoimmune diseases."},{"drug_id":"hydroxychloroquine-pill","indication_name":"Plasmodium Ovale Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"hydroxychloroquine-pill","company_name":"Sanofi","drug_phase":"discontinued","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":null,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and modulating the immune system to treat autoimmune diseases."},{"drug_id":"rilonacept","indication_name":"Cryopyrin associated periodic syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arcalyst","generic_name":"RILONACEPT","company_name":"Regeneron","drug_phase":"marketed","molecular_target":"Interleukin-1 beta","drug_class":"","quality_score":55,"revenue":null,"mechanism":"Arcalyst works by binding to Interleukin-1 beta, preventing its interaction with its receptor and reducing inflammation."},{"drug_id":"enoxaparin-sodium","indication_name":"Prevention of clot formation during haemodialysis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lovenox (Preservative Free)","generic_name":"ENOXAPARIN SODIUM","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Antithrombin-III","drug_class":"Low Molecular Weight Heparin","quality_score":10,"revenue":null,"mechanism":"Lovenox works by enhancing the activity of antithrombin-III to inhibit blood clotting."},{"drug_id":"aldactone","indication_name":"Edema in cirrhotic patients unresponsive to fluid and sodium restriction","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aldactone","generic_name":"Spironolactone","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Aldosterone receptors at aldosterone-dependent sodium-potassium exchange site in distal convoluted renal tubule","drug_class":"Potassium-sparing diuretic, aldosterone antagonist","quality_score":66,"revenue":null,"mechanism":"Aldosterone antagonist causing increased sodium and water excretion while retaining potassium."},{"drug_id":"kineret","indication_name":"Cryopyrin associated periodic syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Anakinra","generic_name":"Kineret","company_name":"Biovitrum Ab","drug_phase":"marketed","molecular_target":"Interleukin-1 receptor, type I","drug_class":"Interleukin-1 Receptor Antagonist","quality_score":41,"revenue":null,"mechanism":""},{"drug_id":"levoxyl","indication_name":"TSH suppression in thyrotropin-dependent well-differentiated thyroid cancer - adjunct to radioiodine therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Levoxyl","generic_name":"Levothyroxine Sodium","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Thyroid receptor proteins attached to DNA","drug_class":"Thyroid hormone replacement","quality_score":10,"revenue":null,"mechanism":"Levothyroxine binds thyroid receptors in cell nuclei to activate gene transcription and protein synthesis."},{"drug_id":"mefloquine","indication_name":"Chloroquine Resistant Plasmodium Falciparum Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"mefloquine","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"chloroquine","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aralen","generic_name":"CHLOROQUINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Antimalarial","quality_score":65,"revenue":null,"mechanism":"Aralen works by accumulating in the acidic compartments of the malaria parasite, disrupting its metabolism and ultimately leading to its death."},{"drug_id":"chloroquine","indication_name":"Plasmodium Malariae Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aralen","generic_name":"CHLOROQUINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Antimalarial","quality_score":65,"revenue":null,"mechanism":"Aralen works by accumulating in the acidic compartments of the malaria parasite, disrupting its metabolism and ultimately leading to its death."},{"drug_id":"chloroquine","indication_name":"Plasmodium Ovale Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aralen","generic_name":"CHLOROQUINE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Antimalarial","quality_score":65,"revenue":null,"mechanism":"Aralen works by accumulating in the acidic compartments of the malaria parasite, disrupting its metabolism and ultimately leading to its death."},{"drug_id":"quinine","indication_name":"Chloroquine Resistant Plasmodium Falciparum Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Qualaquin","generic_name":"QUININE","company_name":"Sun Pharm Industries","drug_phase":"marketed","molecular_target":"Sodium channel alpha subunits; brain (Types I, II, III)","drug_class":"Antimalarial","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"ioflupane","indication_name":"suspected dementia with Lewy bodies","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ioflupane I 123","generic_name":"IOFLUPANE","company_name":"Ge Hlthcare Inc","drug_phase":"marketed","molecular_target":"Dopamine transporter (DaT)","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":70,"revenue":null,"mechanism":"Ioflupane I-123 binds to the dopamine transporter (DaT) in the striatum, allowing visualization of brain striata through SPECT imaging."},{"drug_id":"hydroxychloroquine","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"HYDROXYCHLOROQUINE","company_name":"Advanz","drug_phase":"marketed","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":75,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body."},{"drug_id":"hydroxychloroquine","indication_name":"Plasmodium Malariae Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"HYDROXYCHLOROQUINE","company_name":"Advanz","drug_phase":"marketed","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":75,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body."},{"drug_id":"hydroxychloroquine","indication_name":"Plasmodium Ovale Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hydroxychloroquine Sulfate","generic_name":"HYDROXYCHLOROQUINE","company_name":"Advanz","drug_phase":"marketed","molecular_target":"Toll-like receptor 9","drug_class":"Antimalarial","quality_score":75,"revenue":null,"mechanism":"Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body."},{"drug_id":"artesunate-amodiaquine-as-aq","indication_name":"Treatment of acute, uncomplicated Plasmodium falciparum malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"artesunate-amodiaquine (AS-AQ)","company_name":"Yale University","drug_phase":"marketed","molecular_target":"Plasmodium falciparum heme iron (Fe2+), parasite DNA, heme polymerase","drug_class":"Artemisinin derivative + aminoquinoline antimalarial combination","quality_score":22,"revenue":null,"mechanism":""},{"drug_id":"proguanil","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Malarone","generic_name":"PROGUANIL","company_name":"GSK","drug_phase":"marketed","molecular_target":"","drug_class":"Antimalarial [EPC]","quality_score":60,"revenue":null,"mechanism":"Malarone works by inhibiting the parasite's ability to synthesize nucleic acids, ultimately preventing its replication and spread within the body."},{"drug_id":"proguanil","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Malarone","generic_name":"PROGUANIL","company_name":"GSK","drug_phase":"marketed","molecular_target":"","drug_class":"Antimalarial [EPC]","quality_score":60,"revenue":null,"mechanism":"Malarone works by inhibiting the parasite's ability to synthesize nucleic acids, ultimately preventing its replication and spread within the body."},{"drug_id":"artemether","indication_name":"Chloroquine Resistant Plasmodium Falciparum Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Coartem","generic_name":"ARTEMETHER","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Antimalarial [EPC]","quality_score":10,"revenue":null,"mechanism":"Artemether works by rapidly killing malaria parasites in the blood and liver."},{"drug_id":"anakinra","indication_name":"Cryopyrin associated periodic syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Kineret","generic_name":"ANAKINRA","company_name":"Biovitrum Ab","drug_phase":"marketed","molecular_target":"Interleukin-1 receptor, type I","drug_class":"Interleukin-1 Receptor Antagonist [EPC]","quality_score":70,"revenue":null,"mechanism":"Kineret blocks the action of interleukin-1, a protein that promotes inflammation."},{"drug_id":"flumazenil","indication_name":"Benzodiazepine Induced Sedation","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Romazicon","generic_name":"FLUMAZENIL","company_name":"","drug_phase":"marketed","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-5","drug_class":"Benzodiazepine Antagonist [EPC]","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"flumazenil","indication_name":"Benzodiazepine Maintained Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Romazicon","generic_name":"FLUMAZENIL","company_name":"","drug_phase":"marketed","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-5","drug_class":"Benzodiazepine Antagonist [EPC]","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"etelcalcetide","indication_name":"Secondary Hyperparathyroidism in CKD on Hemodialysis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Parsabiv","generic_name":"ETELCALCETIDE","company_name":"Kai Pharms Inc","drug_phase":"marketed","molecular_target":"CaSR","drug_class":"Calcium-sensing Receptor Agonist","quality_score":70,"revenue":null,"mechanism":"Etelcalcetide enhances calcium-sensing receptor activation, reducing PTH secretion."},{"drug_id":"mefloquine-hydrochloride","indication_name":"Chloroquine Resistant Plasmodium Falciparum Malaria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"mefloquine-hydrochloride","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lariam","generic_name":"MEFLOQUINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"Adenosine receptor A2a","drug_class":"Antimalarial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"atovaquone","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mepron","generic_name":"ATOVAQUONE","company_name":"","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2","drug_class":"Antimalarial [EPC]","quality_score":10,"revenue":null,"mechanism":"Mepron works by inhibiting the electron transport chain in the mitochondria of Plasmodium parasites, ultimately leading to their death."},{"drug_id":"atovaquone","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mepron","generic_name":"ATOVAQUONE","company_name":"","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2","drug_class":"Antimalarial [EPC]","quality_score":10,"revenue":null,"mechanism":"Mepron works by inhibiting the electron transport chain in the mitochondria of Plasmodium parasites, ultimately leading to their death."},{"drug_id":"doxycycline","indication_name":"Chloroquine-Resistant Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vibramycin","generic_name":"doxycycline","company_name":"Generic (originally Pfizer)","drug_phase":"marketed","molecular_target":"72 kDa type IV collagenase, Stromelysin-1, Collagenase 3","drug_class":"Tetracycline antibiotic","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"lovenox","indication_name":"Prevention of clot formation during haemodialysis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lovenox","company_name":"University of Monastir","drug_phase":"marketed","molecular_target":"Antithrombin-III","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"enoxaparin","indication_name":"Prevention of clot formation during haemodialysis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Enoxaparin","company_name":"Dana-Farber Cancer Institute","drug_phase":"marketed","molecular_target":"Antithrombin-III","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydroxychloroquin","indication_name":"Plasmodium Falciparum Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxychloroquin","company_name":"Children's Hospital of Fudan University","drug_phase":"marketed","molecular_target":"Transmembrane protein 97, Alpha-1D adrenergic receptor, Alpha-2A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydroxychloroquin","indication_name":"Plasmodium Malariae Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxychloroquin","company_name":"Children's Hospital of Fudan University","drug_phase":"marketed","molecular_target":"Transmembrane protein 97, Alpha-1D adrenergic receptor, Alpha-2A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydroxychloroquin","indication_name":"Plasmodium Ovale Malaria Prevention","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Hydroxychloroquin","company_name":"Children's Hospital of Fudan University","drug_phase":"marketed","molecular_target":"Transmembrane protein 97, Alpha-1D adrenergic receptor, Alpha-2A adrenergic receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"flumazenil","indication_name":"Benzodiazepine Toxicity","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Romazicon","generic_name":"FLUMAZENIL","company_name":"","drug_phase":"marketed","molecular_target":"Gamma-aminobutyric acid receptor subunit alpha-5","drug_class":"Benzodiazepine Antagonist [EPC]","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"loteprednol-etabonate-and-tobramycin","indication_name":"Penetration of foreign bodies in the eye","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"loteprednol etabonate and tobramycin","company_name":"Bausch & Lomb Incorporated","drug_phase":"marketed","molecular_target":"","drug_class":"Aminoglycoside Antibacterial [EPC]","quality_score":31,"revenue":null,"mechanism":null},{"drug_id":"vasopressin","indication_name":"Vasodilatory Shock Treatment","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"VASOPRESSIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":9,"revenue":null,"mechanism":null},{"drug_id":"sucrose","indication_name":"Iron Deficiency Anemia in CKD on Hemodialysis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SUCROSE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Parenteral Iron Replacement [EPC]","quality_score":15,"revenue":null,"mechanism":null}],"pipeline":[{"drug_id":"rimegepant-75-mg","indication_name":"Preventive treatment of episodic migraine","indication_type":"pipeline","phase":"Phase 4","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rimegepant 75 MG","generic_name":"rimegepant-75-mg","company_name":"Pfizer Inc.","drug_phase":"preclinical","molecular_target":"Calcitonin gene-related peptide (CGRP) receptor","drug_class":"CGRP receptor antagonist (gepant)","quality_score":25,"revenue":null,"mechanism":"Rimegepant selectively antagonizes the calcitonin gene-related peptide (CGRP) receptor to block migraine pain signaling."},{"drug_id":"phytonadione","indication_name":"Coronary artery calcification in hemodialysis patients","indication_type":"pipeline","phase":"Phase 2","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PHYTONADIONE","company_name":"","drug_phase":"marketed","molecular_target":"Vitamin K epoxide reductase complex subunit 1 (VKORC1)","drug_class":"Vitamin K [EPC]","quality_score":65,"revenue":null,"mechanism":""}],"offLabel":[],"totalMarketed":48,"totalPipeline":2},"trials":{"data":[{"nct_id":"NCT04856436","title":"Maternal and Neonatal Outcomes Following Exposure to Benzodiazepines During Pregnancy","phase":"","overall_status":"COMPLETED","enrollment_count":3094227,"lead_sponsor_name":"Sungkyunkwan University","has_results":false},{"nct_id":"NCT04735835","title":"Personalized Responses to Dietary Composition Trial 3","phase":"NA","overall_status":"RECRUITING","enrollment_count":250000,"lead_sponsor_name":"Zoe Global Limited","has_results":false},{"nct_id":"NCT05052502","title":"Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand","phase":"NA","overall_status":"UNKNOWN","enrollment_count":49118,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03783299","title":"Targeted Active Case Detection Among High Risk Populations in Southern Lao Peoples Democratic Republic","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":39968,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06106568","title":"An Observational Study to Learn More About the Impact of Gadoxetate Sodium-Enhanced Magnetic Resonance Imaging (EOB-MRI) When Used to Diagnose the Spread of Cancer From the Pancreas to the Liver in Japanese People Under Real-World Conditions","phase":"","overall_status":"COMPLETED","enrollment_count":39624,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04416945","title":"Targeting High Risk Populations With Enhanced Reactive Case Detection in Southern Lao Peoples Democratic Republic","phase":"NA","overall_status":"UNKNOWN","enrollment_count":31443,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT02721186","title":"Effectiveness of Mass Drug Administration for Reducing Seasonal Malaria Transmission in Zanzibar","phase":"NA","overall_status":"COMPLETED","enrollment_count":22500,"lead_sponsor_name":"Ulrika Morris","has_results":false},{"nct_id":"NCT05023564","title":"PUMCH Dementia Longitudinal Cohort Study","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06665815","title":"A National Screening Program for Islet Autoantibodies Among First-degree Relatives of T1D Patients","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Rabin Medical Center","has_results":false},{"nct_id":"NCT06923592","title":"Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":19200,"lead_sponsor_name":"London School of Hygiene and Tropical Medicine","has_results":false},{"nct_id":"NCT03220139","title":"Type of Dietary Fat Intakes in Relation to Mortality in US Adults: An Iso-caloric Substitution Analysis From the American National Health and Nutrition Examination Survey Linked to the US Mortality Registry","phase":"","overall_status":"COMPLETED","enrollment_count":18372,"lead_sponsor_name":"North-West University, South Africa","has_results":false},{"nct_id":"NCT07135115","title":"Targeting Lifestyle to Improve Colorectal Cancer Screening","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":16000,"lead_sponsor_name":"Norwegian Institute of Public Health","has_results":false},{"nct_id":"NCT06068530","title":"Mass Vaccine and Drug Administration, Bangladesh","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT03672448","title":"The China Longitudinal Aging Study of Cognitive Impairment","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Shanghai Mental Health Center","has_results":false},{"nct_id":"NCT05735457","title":"A Short, Animated Storytelling Video to Increase Knowledge About Sodium Intake as a Cardiovascular Risk Factor","phase":"NA","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"University Hospital Freiburg","has_results":false},{"nct_id":"NCT05611606","title":"Welfare Benefits in Functional Somatic Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":9656,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT05811663","title":"Health Care Use and Costs of Functional Somatic Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":9656,"lead_sponsor_name":"Aarhus University Hospital","has_results":false},{"nct_id":"NCT01190930","title":"Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9350,"lead_sponsor_name":"Children's Oncology Group","has_results":true},{"nct_id":"NCT03224741","title":"Behavioral Economics Field Experiment in HIV Testing","phase":"NA","overall_status":"COMPLETED","enrollment_count":7720,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT05690841","title":"FocaL Mass Drug Administration for Vivax Malaria Elimination","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":7530,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06006715","title":"Psychiatric Disorders and Functional Somatic Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":7493,"lead_sponsor_name":"Aarhus University Hospital","has_results":false},{"nct_id":"NCT05631860","title":"Psychological Risk Factors for Functional Somatic Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":7493,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT03283033","title":"School Lunch Salad Bars and Fruit and Vegetable Consumption","phase":"NA","overall_status":"TERMINATED","enrollment_count":7491,"lead_sponsor_name":"Arizona State University","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT06113042","title":"KeySteps@JC Phase Two Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT04093765","title":"Mass Screening and Treatment for Reduction of Falciparum Malaria","phase":"NA","overall_status":"COMPLETED","enrollment_count":5542,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT05394623","title":"Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study)","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT00001373","title":"Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT06801691","title":"The Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe","phase":"NA","overall_status":"RECRUITING","enrollment_count":4500,"lead_sponsor_name":"EUthyroid","has_results":false},{"nct_id":"NCT04388540","title":"Caribbean Island Urinary Iodine Survey 2018","phase":"","overall_status":"COMPLETED","enrollment_count":3080,"lead_sponsor_name":"Swiss Federal Institute of Technology","has_results":false},{"nct_id":"NCT03176706","title":"Assessment of Dried Blood Spot Thyroglobulin and Urinary Iodine Concentration in Pregnant Women","phase":"","overall_status":"COMPLETED","enrollment_count":2900,"lead_sponsor_name":"Swiss Federal Institute of Technology","has_results":false},{"nct_id":"NCT03924414","title":"Trial of Parkinson's And Zoledronic Acid","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2650,"lead_sponsor_name":"California Pacific Medical Center Research Institute","has_results":false},{"nct_id":"NCT07103694","title":"i-NEED: NEw migrainE Drugs Database","phase":"","overall_status":"RECRUITING","enrollment_count":2641,"lead_sponsor_name":"IRCCS San Raffaele Roma","has_results":false},{"nct_id":"NCT03923725","title":"A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2583,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT00322738","title":"Time to Infection With Malaria Parasites","phase":"","overall_status":"COMPLETED","enrollment_count":2558,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT00322816","title":"Malaria Prevalence in Children","phase":"","overall_status":"COMPLETED","enrollment_count":2552,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03479866","title":"Personalised Responses to Dietary Composition Trial","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT05178875","title":"Estimation of Dietary Nitrate Intake in a Representative UK cohort_V1","phase":"","overall_status":"COMPLETED","enrollment_count":2444,"lead_sponsor_name":"University of Reading","has_results":false},{"nct_id":"NCT01578200","title":"Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2309,"lead_sponsor_name":"Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan","has_results":false},{"nct_id":"NCT04031638","title":"Thyroid Cancer Database","phase":"","overall_status":"UNKNOWN","enrollment_count":2300,"lead_sponsor_name":"Centre Georges Francois Leclerc","has_results":false},{"nct_id":"NCT03887247","title":"Reducing Concurrent Opioid-Benzodiazepine Prescriptions","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2234,"lead_sponsor_name":"Walter Reed National Military Medical Center","has_results":false},{"nct_id":"NCT05677581","title":"Longitudinal Study on the Influence of Iodine Nutrition Status on Thyroid Function of Childbearing Age Women During Pregnancy and 6 Weeks Postpartum","phase":"","overall_status":"UNKNOWN","enrollment_count":2100,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT01950819","title":"Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2037,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT03290118","title":"The Efficacy of Front-of-package Labelling Schemes: an Experimental Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":2008,"lead_sponsor_name":"University of Toronto","has_results":false},{"nct_id":"NCT03654105","title":"Screening and Multiple Intervention on Lung Epidemics","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","has_results":false},{"nct_id":"NCT03710148","title":"The Effect of Iodine Intakes on Maternal and Infant Health and the Study of Iodine RNI for Different Stages of Pregnancy","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Wanqi Zhang","has_results":false},{"nct_id":"NCT07314190","title":"Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental Disorder","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1799,"lead_sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","has_results":false},{"nct_id":"NCT04806633","title":"Dapagliflozin to Prevent the Incidence of Contrast Induced Nephropathy After Heart Catheterization and Percutaneous Coronary Intervention","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":1722,"lead_sponsor_name":"G.Gennimatas General Hospital","has_results":false},{"nct_id":"NCT05842954","title":"Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1720,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT01160562","title":"Pilot Study to Estimate the Burden and Distribution of Plasmodium Falciparum Malaria in Kalifabougou, Mali in Preparation for a Prospective Cohort Study of Naturally-Acquired Malaria Immunity","phase":"","overall_status":"COMPLETED","enrollment_count":1719,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}